Sporadic late-onset nemaline myopathy: a case report of a treatable cause of cardiac failure.

Autologous stem cell transplantation Cardiac failure Case report Nemaline rods SLONM

Journal

European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 15 05 2020
revised: 15 07 2020
accepted: 12 11 2020
entrez: 8 2 2021
pubmed: 9 2 2021
medline: 9 2 2021
Statut: epublish

Résumé

Sporadic late-onset nemaline myopathy (SLONM) is a rare, acquired, adult-onset myopathy, characterized by proximal muscle weakness and the pathognomonic feature of nemaline rods in muscle fibres. Sporadic late-onset nemaline myopathy is associated with cardiac pathology in case reports and small case series, but the severity of cardiac disease is generally mild and rarely requires specific treatment. This case report describes severe heart failure as an early feature of SLONM, which responded to specific treatments, and highlights SLONM as a potentially reversible cause of heart failure. A 65-year-old woman presented with progressive muscle weakness and a dramatic loss of muscle bulk in her thighs, followed by progressive effort breathlessness over an 18-month period. She required a wheelchair to ambulate. A diagnosis of SLONM was made on histopathological assessment of a muscle biopsy along with electron microscopy. An echocardiogram showed a severely dilated and impaired left ventricle. She was treated with standard heart failure medications and autologous stem cell transplantation, which resulted in improvement of both her cardiac and muscle function, and allowed her to walk again and resume near-normal functional performance status. Cardiomyopathy can be a relatively early and life-threatening feature of SLONM and even in severe cases can be effectively treated with standard heart failure medications and autologous stem cell transplantation.

Sections du résumé

BACKGROUND BACKGROUND
Sporadic late-onset nemaline myopathy (SLONM) is a rare, acquired, adult-onset myopathy, characterized by proximal muscle weakness and the pathognomonic feature of nemaline rods in muscle fibres. Sporadic late-onset nemaline myopathy is associated with cardiac pathology in case reports and small case series, but the severity of cardiac disease is generally mild and rarely requires specific treatment. This case report describes severe heart failure as an early feature of SLONM, which responded to specific treatments, and highlights SLONM as a potentially reversible cause of heart failure.
CASE SUMMARY METHODS
A 65-year-old woman presented with progressive muscle weakness and a dramatic loss of muscle bulk in her thighs, followed by progressive effort breathlessness over an 18-month period. She required a wheelchair to ambulate. A diagnosis of SLONM was made on histopathological assessment of a muscle biopsy along with electron microscopy. An echocardiogram showed a severely dilated and impaired left ventricle. She was treated with standard heart failure medications and autologous stem cell transplantation, which resulted in improvement of both her cardiac and muscle function, and allowed her to walk again and resume near-normal functional performance status.
DISCUSSION CONCLUSIONS
Cardiomyopathy can be a relatively early and life-threatening feature of SLONM and even in severe cases can be effectively treated with standard heart failure medications and autologous stem cell transplantation.

Identifiants

pubmed: 33554019
doi: 10.1093/ehjcr/ytaa480
pii: ytaa480
pmc: PMC7850604
doi:

Types de publication

Case Reports

Langues

eng

Pagination

ytaa480

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Clin Neuropathol. 1993 May-Jun;12(3):153-5
pubmed: 8391957
Neurology. 2008 Aug 12;71(7):532-4
pubmed: 18565829
Neurology. 2014 Dec 2;83(23):2133-9
pubmed: 25378674
Ann Hematol. 2017 Apr;96(4):695-696
pubmed: 28058489
Bone Marrow Transplant. 2018 Jul;53(7):895-899
pubmed: 29367711
Presse Med. 2017 Jan;46(1):122-125
pubmed: 27818064
Orphanet J Rare Dis. 2017 May 11;12(1):86
pubmed: 28490364
BMC Cardiovasc Disord. 2015 Jan 19;15:5
pubmed: 25597856
Neurology. 2008 Aug 12;71(7):531-2
pubmed: 18565830
J Neurol. 2018 Mar;265(3):542-551
pubmed: 29356967

Auteurs

Casmir Turnquist (C)

University of Oxford Medical School, John Radcliffe Hospital, Oxford, UK.

Joanna C Grogono (JC)

Department of Cardiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.

Monika Hofer (M)

Department of Neuropathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Alex Pitcher (A)

Department of Cardiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.

Classifications MeSH